HB 353

  • Pennsylvania House Bill
  • 2017-2018 Regular Session
  • Introduced in House
  • Passed House Jun 20, 2017
  • Passed Senate Oct 16, 2018
  • Signed by Governor Oct 24, 2018

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for definitions and for professional prescription, administration, and dispensing.

Votes


Actions


Oct 24, 2018

House

Approved by the Governor

Oct 17, 2018

House

Presented to the Governor

House

Signed in Senate

House

Signed in House

House

House concurred in Senate amendments

House

Re-reported on concurrence, as committed

House

Referred to RULES

Oct 16, 2018

Senate

Third consideration and final passage

Sep 24, 2018

Senate

Re-reported as committed

Jun 21, 2018

Senate

Second consideration

Senate

Re-referred to APPROPRIATIONS

Jun 20, 2018

Senate

First consideration

Senate

PN 3779 Reported as amended

Jun 23, 2017

Senate

Referred to HEALTH AND HUMAN SERVICES

Jun 20, 2017

House

Third consideration and final passage

House

Re-reported as committed

Jun 19, 2017

House

Re-reported as committed

House

Re-committed to APPROPRIATIONS

House

PN 2066 Second consideration, with amendments

Jun 06, 2017

House

PN 1911 Reported as amended

House

Re-committed to RULES

House

First consideration

Feb 06, 2017

House

PN 0365 Referred to HEALTH

Bill Text

Bill Text Versions Format
Printer's No. 0365 HTML PDF MSWORD HTML
Printer's No. 1911 HTML PDF MSWORD HTML
Printer's No. 2066 HTML PDF MSWORD HTML PDF
Printer's No. 3779 HTML PDF MSWORD PDF PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Pennsylvania General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.